A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Interventions
BEHAVIORAL

Remote monitoring

See prior description of the intervention.

Trial Locations (5)

10016

New York University, New York

21201

University of Maryland School of Medicine, Baltimore

37212

Vanderbilt University Medical Center, Nashville

45267

University of Cincinnati College of Medicine, Cincinnati

27599-7080

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

Vanderbilt University Medical Center

OTHER

collaborator

New York University

OTHER

collaborator

University of Cincinnati

OTHER

collaborator

Synchronyx, LLC

UNKNOWN

lead

University of Maryland, Baltimore

OTHER